cancer-related fatigue
Conditions
Interventions
Sponsors
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Pathologically confirmed primary lung cancer and colorectal cancer patients with measurable lesions can be evaluated for curative effect (Based on RECIST 1.1 therapeutic efficacy evaluation criteria for solid tumors); 2.meet the diagnostic criteria for cancer-related fatigue; 3. Fatigue Score >= 4.(The degree of fatigue was scored using a 0-10 numerical rating scale, 0 = no fatigue, 10 = most severe fatigue); 4. Patients who agree not to participate in other intervention studies during treatment; 5. Aged 18-80 years, regardless of gender; 6. The estimated survival time is greater than 3 months.
Exclusion criteria
Exclusion criteria: 1. The patient who has severe bleeding or is systemically infected; 2. The patient who has a clear invasion of bone marrow metastases; 3. The patient who has received surgery, chemotherapy, radiotherapy, targeted therapy, immune or other anti-tumor therapy within 1 month; 4. The patient who has used of erythropoietin and blood transfusion in the past 1 month; 5. Patient with severe diseases of heart, liver, kidney and other systems; 6. Pregnant women, lactating women, unconscious patients or patient who is unable to understand and participate in this study; 7. As determined by the researcher, patient is not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Piper fatigue Survey Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| T lymphocyte and B lymphocyte;karnofsky performance score;blood routine examination;Symptom Inventory for TCM; | — |
Countries
China
Contacts
Public ContactCui Ning
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Outcome results
None listed